Nixon Gwilt Law Welcomes Privacy and Femtech Expert Bethany Corbin, Esq., to Firm

Vienna, Virginia Oct 11, 2021 (Issuewire.com) – Bethany Corbin, Esq., joined Nixon Gwilt Law (NGL) as Healthcare Innovation, FemTech & Privacy Attorney & Educator in September. Prior to joining NGL, Corbin worked at a large law firm in Washington, D.C. 

Corbin provides strategic advice to a broad range of healthcare and pharmaceutical clients, including digital health, medtech, life sciences, and telemedicine companies. She has a Health Care LL.M. with a Certificate in Compliance Studies from Loyola University Chicago School of Law. Corbin is also a Certified Information Privacy Professional (CIPP/US) through the International Association of Privacy Professionals and is Certified in Healthcare Compliance (CHC) and Healthcare Privacy Compliance (CHPC) through the Compliance Certification Board. 

Corbin is co-editor of the forthcoming book, Health Care Contracts: A Clause-By-Clause Guide to Drafting and Negotiation, which will be published by the American Health Lawyers Association later this year. Further, Bethany is scheduled to speak at the World Conference on Bioethics, Medical Ethics & Health Law in 2022, where she will discuss the ethical and privacy implications of femtech.

NGL Partner Rebecca Gwilt, Esq., says, “Bethany has a breadth of knowledge across all of our practice areas, and a background in litigation and academics, which will make her a tremendous asset to clients whose businesses are impacted by multiple bodies of law. As a Certified Information Privacy Professional (CIPP), Bethany will help digital health, medtech, and life science clients understand the nuances of overlapping state, federal, and international privacy laws so that they can implement robust internal controls and close business faster.”

NGL seeks attorneys who are forward-thinking, tech-savvy, and entrepreneurial, just like their clients. Bethany Corbin fits that mold, and she’ll be a valuable asset in working with novel and disruptive healthcare and life sciences companies seeking to transform how people receive and experience healthcare.